# Molina Healthcare, Inc.: Form 10-Q for the period ended Mar 31, 2026

- Company: [Molina Healthcare, Inc.](/companies/moh.md) (CIK 1179929)
- Form: 10-Q
- Filed: 2026-04-23
- Accepted by EDGAR: Apr 23, 2026, 10:11 ET
- Period: 2026-03-31
- Accession: 0001179929-26-000023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1179929/000117992926000023/moh-20260331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1179929/000117992926000023/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2026-01-01 to 2026-03-31 | $10.80bn | us-gaap:Revenues |
| Cost of revenue | 3 months, 2026-01-01 to 2026-03-31 | $9.27bn | us-gaap:CostOfGoodsAndServicesSold |
| Operating income | 3 months, 2026-01-01 to 2026-03-31 | $83.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2026-01-01 to 2026-03-31 | $54.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2026-01-01 to 2026-03-31 | $15.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2026-01-01 to 2026-03-31 | $14.0m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2026-01-01 to 2026-03-31 | $0.27 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2026-01-01 to 2026-03-31 | $0.27 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2026-01-01 to 2026-03-31 | 51,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2026-01-01 to 2026-03-31 | $1.08bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2026-01-01 to 2026-03-31 | $27.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Share repurchases | 3 months, 2026-01-01 to 2026-03-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2026-03-31 | $5.31bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2026-03-31 | $13.33bn | us-gaap:AssetsCurrent |
| Total assets | at 2026-03-31 | $16.39bn | us-gaap:Assets |
| Current liabilities | at 2026-03-31 | $8.19bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2026-03-31 | $12.31bn | us-gaap:Liabilities |
| Long-term debt | at 2026-03-31 | $3.77bn | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2026-03-31 | $4.08bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1179929/000117992926000023/moh-20260331.htm

Filed Apr 23, 2026.
Source: SEC EDGAR, the filing index for accession 0001179929-26-000023. Last ingested by Listed: Nov 15, 2026, 00:39 ET. No prices; not investment advice.
